Naltrexone and Ergocalciferol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Naltrexone (naltrexone) and Ergocalciferol (ergocalciferol). Common drug interactions include lactose intolerance among females and fall among males.

The phase IV clinical study analyzes what interactions people have when they take Naltrexone and Ergocalciferol. It is created by eHealthMe based on reports of 73 people who take the same drugs from the FDA, and is updated regularly.

What is Naltrexone?

Naltrexone has active ingredients of naltrexone. eHealthMe is studying from 4,833 Naltrexone users. Check the latest studies of Naltrexone.

What is Ergocalciferol?

Ergocalciferol has active ingredients of ergocalciferol. It is often used in rickets. eHealthMe is studying from 32,652 Ergocalciferol users. Check the latest studies of Ergocalciferol.



On Jul, 11, 2026

73 people who take Naltrexone and Ergocalciferol together, and have interactions are studied.

Naltrexone and Ergocalciferol drug interactions.

What are the common drug interactions of Naltrexone and Ergocalciferol, by gender? *:

female:

  1. Lactose intolerance (inability to digest lactose)
  2. Ligament sprain (ligament stretched)
  3. Lung disorder (lung disease)
  4. Migraine (headache)
  5. Nephrolithiasis (calculi in the kidneys)
  6. Orthostatic hypotension (a medical condition consisting of a sudden decrease in blood pressure when a person stands up)
  7. Postural orthostatic tachycardia syndrome (abnormal increase in heart rate on becoming upright)
  8. Psoriatic arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop)
  9. Restless legs syndrome (a powerful urge to move your legs)
  10. Rosacea (a skin condition that causes facial redness)

male:

  1. Fall
  2. Ageusia (loss of taste functions of the tongue)
  3. Skin haemorrhage (bleeding into skin)
  4. Skin lesion
  5. Stomatitis (inflammation of mucous membrane of mouth)
  6. Tongue discolouration (colour change of tongue)
  7. Tremor (trembling or shaking movements in one or more parts of your body)
  8. Weight decreased
  9. Wound complication
  10. Autoimmune disorder (a condition in which the immune system attacks the body's normal substances and tissue)

What are the common drug interactions of Naltrexone and Ergocalciferol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Ankylosing spondylitis (type of arthritis affecting the spine)
  2. Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
  3. Osteomalacia (softening of the bones due to a lack of vitamin d)
  4. Attention deficit hyperactivity disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness)
  5. Hypertension (high blood pressure)
  6. Back pain
  7. Sinusitis (inflammation of sinus)

30-39:

  1. Abdominal discomfort
  2. Alopecia (absence of hair from areas of the body)
  3. Cough
  4. Dactylitis (dactylitis or sausage digit is inflammation of an entire digit (a finger or toe), and can be painful)
  5. Dyspnoea (difficult or laboured respiration)
  6. Enthesopathy (disorder of entheses (bone attachments))
  7. Psoriasis (immune-mediated disease that affects the skin)
  8. Rash
  9. Rectal haemorrhage (bleeding from anus)
  10. Spinal osteoarthritis (joint cartilage loss in spine)

40-49:

  1. Bladder disorder
  2. Fall
  3. Feeling of body temperature change
  4. Foot fracture
  5. Lower limb fracture
  6. Panic attack
  7. Patella fracture
  8. Somnambulism (sleep walking)
  9. Therapeutic response decreased (less preventive response)
  10. Tooth loss

50-59:

  1. Contusion (a type of hematoma of tissue in which capillaries)
  2. Dry eye (lack of adequate tears)
  3. Gait disturbance
  4. Grip strength decreased
  5. Hypertension (high blood pressure)
  6. Immune system disorder
  7. Joint swelling
  8. Leukopenia (less number of white blood cells in blood)
  9. Pain
  10. Psoriasis (immune-mediated disease that affects the skin)

60+:

  1. Fall
  2. Weight decreased
  3. Lower limb fracture
  4. Skin haemorrhage (bleeding into skin)
  5. Skin lesion
  6. Stomatitis (inflammation of mucous membrane of mouth)
  7. Tongue discolouration (colour change of tongue)
  8. Tremor (trembling or shaking movements in one or more parts of your body)
  9. Wound complication
  10. Autoimmune disorder (a condition in which the immune system attacks the body's normal substances and tissue)

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 25 people, 34.25%
  2. Growth Hormone Deficiency: 15 people, 20.55%
  3. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 11 people, 15.07%
  4. Inflammation: 10 people, 13.70%
  5. Skin Disorder (skin disease): 9 people, 12.33%
  6. Psoriasis (immune-mediated disease that affects the skin): 9 people, 12.33%
  7. Pain: 9 people, 12.33%
  8. Drowsiness: 6 people, 8.22%

* Approximation only. Some reports may have incomplete information.

Do you take Naltrexone and Ergocalciferol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Naltrexone and Ergocalciferol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Naltrexone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ergocalciferol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Naltrexone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ergocalciferol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on naltrexone and ergocalciferol (the active ingredients of Naltrexone and Ergocalciferol, respectively), and Naltrexone and Ergocalciferol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: